Novo Nordisk
NVO
#103
Rank
โ‚น15.060 T
Marketcap
โ‚น3,393
Share price
-0.07%
Change (1 day)
-41.76%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

ESG Reports

Thumbnail Novo Nordisk ESG Report 2024

ESG Report 2024

Language: English

View ESG Report